| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Endocrinology, Vol 137, 1798-1803, Copyright © 1996 by Endocrine Society
ARTICLES |
MF Walsh, M Barazi, G Pete, R Muniyappa, JC Dunbar and JR Sowers
Department of Internal Medicine, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.
Although most insulin-like growth factor I (IGF-I) in the circulation is generated by the liver, the hormone is also produced locally by the vasculature, suggesting its potential importance in regulation of regional blood flow. Accordingly, we studied the effects of in vivo exposure to IGF-I (5.1 nmol, i.v.) as well as in vitro incubation (100 nM) on endothelium-intact rat tail artery contractile responses to KCl and norepinephrine (NE). Systemic administration of IGF-I resulted in transient lowering of blood pressure, with maximal reduction occurring at 15 min and a return to baseline by 60 min. Maximal contractility of rings removed from animals 90 min after a bolus injection of IGF-I, when blood pressure had returned to normal, was significantly reduced for both KCl (58%) and NE (51%) without a change in sensitivity. Similar data were obtained when rings from untreated animals were preincubated in vitro for 90 min; maximal contractility in response to KCl was decreased by 31% and that to NE by 22%. L-Nitroarginine methyl ester, an inhibitor of nitric oxide (NO) production, administered in vivo before IGF-I or added to the bath buffer reversed the attenuation. The nearly identical in vivo and in vitro results suggest that the observed diminution in contractility is a direct effect of IGF-I on the vasculature, probably mediated in large part by the release of NO. This idea is supported by our observation that IGF-I stimulates NO production in intact vessels. Further, the latency required indicates that rather complex mechanisms involving actions common on both receptor- and nonreceptor-mediated events are initiated by IGF-I and/or NO.
This article has been cited by other articles:
 |
|
 |
|
  F. Perticone, A. Sciacqua, M. Perticone, I. Laino, S. Miceli, I. Care', G. Galiano Leone, F. Andreozzi, R. Maio, and G. Sesti Low-Plasma Insulin-Like Growth Factor-I Levels Are Associated with Impaired Endothelium-Dependent Vasodilatation in a Cohort of Untreated, Hypertensive Caucasian Subjects J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2806 - 2810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. A. Cooper, A. Whaley-Connell, J. Habibi, Y. Wei, G. Lastra, C. Manrique, S. Stas, and J. R. Sowers Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2009 - H2023. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Marini, E. Succurro, S. Frontoni, M. L. Hribal, F. Andreozzi, R. Lauro, F. Perticone, and G. Sesti Metabolically Healthy but Obese Women Have an Intermediate Cardiovascular Risk Profile Between Healthy Nonobese Women and Obese Insulin-Resistant Women Diabetes Care, August 1, 2007; 30(8): 2145 - 2147. [Full Text] [PDF]
|
|
|
|
 |
|
 P. Hovind, S. Lamberts, W. Hop, J. Deinum, L. Tarnow, H.-H. Parving, and J. A M J L Janssen An IGF-I gene polymorphism modifies the risk of developing persistent microalbuminuria in type 1 diabetes Eur. J. Endocrinol., January 1, 2007; 156(1): 83 - 90. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Yazdanpanah, F. A Sayed-Tabatabaei, J. A M J L Janssen, I. Rietveld, A. Hofman, T. Stijnen, H. A P Pols, S. W J Lamberts, J. C M Witteman, and C. M van Duijn IGF-I gene promoter polymorphism is a predictor of survival after myocardial infarction in patients with type 2 diabetes. Eur. J. Endocrinol., November 1, 2006; 155(5): 751 - 756. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. T. Nguyen, N. Cao, J. L. Short, and P. J. White Intravenous Insulin-like Growth Factor-I Receptor Antisense Treatment Reduces Angiotensin Receptor Expression and Function in Spontaneously Hypertensive Rats J. Pharmacol. Exp. Ther., September 1, 2006; 318(3): 1171 - 1177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kobayashi, T. Matsumoto, and K. Kamata IGF-I-induced enhancement of contractile response in organ-cultured aortae from diabetic rats is mediated by sustained thromboxane A2 release from endothelial cells J. Endocrinol., August 1, 2005; 186(2): 367 - 376. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Colao, C. Di Somma, F. Rota, S. Di Maio, M. Salerno, A. Klain, S. Spiezia, and G. Lombardi Common Carotid Intima-Media Thickness in Growth Hormone (GH)-Deficient Adolescents: A Prospective Study after GH Withdrawal and Restarting GH Replacement J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2659 - 2665. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Wei, Y.-J. Chen, D. Li, R. Gu, and W.-H. Wang Dual effect of insulin-like growth factor on the apical 70-pS K channel in the thick ascending limb of rat kidney Am J Physiol Cell Physiol, June 1, 2004; 286(6): C1258 - C1263. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Sowers Insulin resistance and hypertension Am J Physiol Heart Circ Physiol, May 1, 2004; 286(5): H1597 - H1602. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. E. Rey and P. J. Pagano The Reactive Adventitia: Fibroblast Oxidase in Vascular Function Arterioscler. Thromb. Vasc. Biol., December 1, 2002; 22(12): 1962 - 1971. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Tivesten, E. Bollano, I. Andersson, S. Fitzgerald, K. Caidahl, K. Sjogren, O. Skott, J.-L. Liu, R. Mobini, O. G. P. Isaksson, et al. Liver-Derived Insulin-Like Growth Factor-I Is Involved in the Regulation of Blood Pressure in Mice Endocrinology, November 1, 2002; 143(11): 4235 - 4242. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kobayashi and K. Kamata Short-term insulin treatment and aortic expressions of IGF-1 receptor and VEGF mRNA in diabetic rats Am J Physiol Heart Circ Physiol, November 1, 2002; 283(5): H1761 - H1768. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. J. Irving, M. N. Carson, D. J. Webb, and B. R. Walker Peripheral Vascular Structure and Function in Men with Contrasting GH Levels J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3309 - 3314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. R. Standley, M. A. Stanley, and P. Senechal Activation of mitogenic and antimitogenic pathways in cyclically stretched arterial smooth muscle Am J Physiol Endocrinol Metab, December 1, 2001; 281(6): E1165 - E1171. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. S. Khan, C. D. Lynch, D. C. Sane, M. C. Willingham, and W. E. Sonntag Growth Hormone Increases Regional Coronary Blood Flow and Capillary Density in Aged Rats J. Gerontol. A Biol. Sci. Med. Sci., August 1, 2001; 56(8): B364 - 371. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Vecchione, S. Colella, L. Fratta, M. T. Gentile, G. Selvetella, G. Frati, B. Trimarco, and G. Lembo Impaired Insulin-Like Growth Factor I Vasorelaxant Effects in Hypertension Hypertension, June 1, 2001; 37(6): 1480 - 1485. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Zhao, R. L. Sutliff, C. S. Weber, J. Wang, J. Lorenz, R. J. Paul, and J. A. Fagin Smooth Muscle-Targeted Overexpression of Insulin-Like Growth Factor I Results in Enhanced Vascular Contractility Endocrinology, February 1, 2001; 142(2): 623 - 632. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Cifuentes, F. E. Rey, O. A. Carretero, and P. J. Pagano Upregulation of p67phox and gp91phox in aortas from angiotensin II-infused mice Am J Physiol Heart Circ Physiol, November 1, 2000; 279(5): H2234 - H2240. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. L. Oltman, N. L. Kane, D. D. Gutterman, R. S. Bar, and K. C. Dellsperger Mechanism of coronary vasodilation to insulin and insulin-like growth factor I is dependent on vessel size Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E176 - E181. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Schuler-Luttmann, G. Monnig, A. Enbergs, H. Schulte, G. Breithardt, G. Assmann, S. Kerber, and A. von Eckardstein Insulin-Like Growth Factor-Binding Protein-3 Is Associated With the Presence and Extent of Coronary Arteriosclerosis Arterioscler. Thromb. Vasc. Biol., April 1, 2000; 20 (4): e10 - e15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Ren, L. Jefferson, J. R. Sowers, and R. A. Brown Influence of Age on Contractile Response to Insulin-Like Growth Factor 1 in Ventricular Myocytes From Spontaneously Hypertensive Rats Hypertension, December 1, 1999; 34(6): 1215 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. J. Dominguez, M. Barbagallo, J. R. Sowers, and L. M. Resnick Magnesium Responsiveness to Insulin and Insulin-Like Growth Factor I in Erythrocytes from Normotensive and Hypertensive Subjects J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4402 - 4407. [Abstract] [Full Text]
|
|
|
|
|
|
J. Ren, M. F. Walsh, M. Hamaty, J. R. Sowers, and R. A. Brown Altered inotropic response to IGF-I in diabetic rat heart: influence of intracellular Ca2+ and NO Am J Physiol Heart Circ Physiol, September 1, 1998; 275(3): H823 - H830. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Hasdai, D. R. Holmes Jr., D. M. Richardson, U. Izhar, and A. Lerman Insulin and IGF-I attenuate the coronary vasoconstrictor effects of endothelin-1 but not of sarafotoxin 6c Cardiovasc Res, September 1, 1998; 39(3): 644 - 650. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hasdai, R. A. Rizza, D. R. Holmes Jr, D. M. Richardson, P. Cohen, and A. Lerman Insulin and Insulin-like Growth Factor-I Cause Coronary Vasorelaxation In Vitro Hypertension, August 1, 1998; 32(2): 228 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. M. Abdelbaky, G. B. Brock, and H. Huynh Improvement of Erectile Function in Diabetic Rats by Insulin: Possible Role of the Insulin-Like Growth Factor System Endocrinology, July 1, 1998; 139(7): 3143 - 3147. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. M. J. L. Janssen, R. P. Stolk, H. A. P. Pols, D. E. Grobbee, and S. W. J. Lamberts Serum Total IGF-I, Free IGF-I, and IGFBP-1 Levels in an Elderly Population : Relation to Cardiovascular Risk Factors and Disease Arterioscler. Thromb. Vasc. Biol., February 1, 1998; 18(2): 277 - 282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Tonshoff, F. J. Kaskel, and L. C. Moore Effects of insulin-like growth factor I on the renal juxtamedullary microvasculature Am J Physiol Renal Physiol, January 1, 1998; 274(1): F120 - F128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. R. Sowers Insulin and Insulin-Like Growth Factor in Normal and Pathological Cardiovascular Physiology Hypertension, March 1, 1997; 29(3): 691 - 699. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
